BCAX CLUSTER SEC Filing Analysis

Final — all horizons settled through T+60d

BCAX ▲ +3.61% at T+60d

NEUTRAL call ✓ call won +3.61% · α vs SPY -6.88% · entry $19.40 → $20.10

Currently $21.69 · +11.80% from $19.40 entry

Entry anchored
Mar 13, 03:59 PM ET
via Databento tick

T+1d

-0.41%

call -0.41% · α -0.68%

$19.32

settled 3mo ago

T+5d

-5.21%

call -5.21% · α -3.16%

$18.39

settled 3mo ago

T+20d

+18.45%

call +18.45% · α +14.67%

$22.98

settled 2mo ago

T+60d

+3.61%

call +3.61% · α -6.88%

$20.10

settled 4d ago

Price Chart

Loading chart...

Executive Summary

CEO Claire Mazumdar and President Ryan Cohlhepp of Bicara Therapeutics (BCAX) exercised stock options and sold shares in a coordinated cluster over four days, generating $302,422 in open-market sales. The transactions represent modest insider selling following derivative exercises, with total proceeds under 0.1% of the company's $1.0B market cap.

Key Financial Metrics

Direction

selling

Total Value

$302.4K

Insiders

2

Actionable Insight

Monitor for further selling or commentary around next earnings — current activity is routine for executives managing equity compensation, but continued outflows could signal caution.

Key Facts

CEO Claire Mazumdar sold 15,000 shares for $282,366 across three days (March 18–20), following full option exercises.
President Ryan Cohlhepp sold 8,000 shares for $157,257 on March 16 after exercising options.
All sales were open-market transactions (code S) preceded by derivative exercises (code M).
Total cash proceeds from selling activity: $302,422 (CEO: $282,366, President: $157,257).
No open-market purchases or grants; all activity is consistent with pre-planned option monetization.

Financial Impact

$302,422 in insider selling, representing 0.03% of BCAX's $1.0B market cap

insider ownershippotential sentiment signal

Risk Factors

Perception of insider pessimism if no offsetting buybacks or positive news follow.
Potential downward pressure if additional executives sell in coming weeks.

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CONTEXT: Insider Cluster Data (12 trades, 7d window)	cluster-BCAX-1774040615039

13 reports for BCAX

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for BCAX — sortable, filterable
	Type				Now
Jun 11, 2026 1d ago	Institutional Cluster BEARISH ★ 5/10	$20.90 awaiting T+5	awaiting T+5	—	$21.69 (−3.80%)
May 26, 2026 17d ago	Insider Cluster NEUTRAL ★ 2/10	$21.58 $20.00	▼ −7.32%	▼ −7.79%	$21.69 (+0.51%)
May 11, 2026 4w ago	8-K NEUTRAL ★ 4/10	$22.92 $19.29	▼ −15.84%	▼ −15.75%	$21.69 (−5.37%)
May 4, 2026 5w ago	Press Release NEUTRAL ★ 2/10	$22.72 $22.92	▲ +0.88%	▼ −2.06%	$21.69 (−4.53%)
Apr 27, 2026 6w ago	DEFA14A NEUTRAL ★ 2/10	$22.48 $22.72	▲ +1.09%	▲ +0.69%	$21.69 (−3.49%)
Apr 20, 2026 7w ago	Insider Cluster NEUTRAL ★ 2/10	$21.28 $23.78	▲ +11.75%	▲ +8.64%	$21.69 (+1.93%)
Apr 15, 2026 8w ago	Insider Cluster NEUTRAL ★ 5/10	$23.72 $23.63	▼ −0.38%	▼ −2.02%	$21.69 (−8.56%)
Apr 15, 2026 8w ago	Insider Cluster BEARISH ★ 7/10	$23.72 $23.63	▲ +0.38%	▲ +2.02%	$21.69 (+8.56%)
Apr 3, 2026 10w ago	Press Release NEUTRAL ★ 2/10	$20.85 $22.14	▲ +6.19%	▲ +2.05%	$21.69 (+4.03%)
Mar 23, 2026 11w ago	Press Release NEUTRAL ★ 3/10	$18.39 $19.04	▲ +3.53%	▲ +7.10%	$21.69 (+17.94%)

US Market Status

Market Closed — Opens Mon (48h 50m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access